Nanoparticle-mediated intravesical delivery of conditioned medium derived from mesenchymal stem cells for interstitial cystitis/bladder pain syndrome treatment
Source abstract
Abstract
Abstract Interstitial cystitis/bladder pain syndrome (IC/BPS) is a critical disease characterized by debilitating pelvic pain associated with lower urinary tract symptoms. Effective therapeutic strategies remain challenging due to their elusive pathogenesis. Mesenchymal stem cell (MSC) therapy offers a promising therapeutic approach for IC/BPS treatment. Yet, the ethical arguments and tumorigenic risks from cell therapy by stem cells restrict the clinical application. Herein, we developed a nanoparticle that encapsulates the conditioned medium (CM) from stem cells and coated with cationic N-trimethyl chitosan chloride (TMC) on the surface to improve the penetration of epithelial barrier in intravesical therapy for IC/BPS. The TMC coating enhanced the accumulation of CM-loaded nanoparticles in the urothelium and subsequently improved the therapeutic efficacy on the mechanical threshold and micturition function through facilitating the effect of anti-inflammation and BDNF/TrkB signaling, which provides a great potential application on the transmucosal delivery platform for intravesical therapy of IC/BPS.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Urinary Bladder and Prostate Research · Urological Disorders and Treatments · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment10.1016/j.juro.2015.01.086 ↗
2. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study10.1016/j.juro.2012.08.088 ↗
3. Biomaterial-assisted drug delivery for interstitial cystitis/bladder pain syndrome treatment10.1039/D0TB02094J ↗
4. Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome10.7150/thno.27559 ↗
5. Umbilical cord-derived mesenchymal stem cells alleviated inflammation and inhibited apoptosis in interstitial cystitis via AKT/mTOR signaling pathway10.1016/j.bbrc.2017.11.072 ↗
6. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-kappaB signaling pathway in vivo and in vitro10.1186/s13287-017-0760-6 ↗
7. The conditioned medium of human embryonic stem cell-derived mesenchymal stem cells alleviates neurological deficits and improves synaptic recovery in experimental stroke10.1002/jcp.29981 ↗
8. Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome10.1016/j.biomaterials.2019.119293 ↗
9. Injectable Gel Form of a Decellularized Bladder Induces Adipose-Derived Stem Cell Differentiation into Smooth Muscle Cells In Vitro10.3390/ijms21228608 ↗
10. Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study10.1080/10717544.2019.1642417 ↗
11. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption10.1021/acsami.5b03555 ↗
12. Normalization of magnesium deficiency attenuated mechanical allodynia, depressive-like behaviors, and memory deficits associated with cyclophosphamide-induced cystitis by inhibiting TNF-alpha/NF-kappaB signaling in female rats10.1186/s12974-020-01786-5 ↗
13. A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial10.1186/s13287-021-02246-4 ↗
14. Mesenchymal stem cell/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure10.1021/acsnano.8b00553 ↗
15. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC)10.1007/s11095-020-02848-2 ↗
16. Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy10.2147/IJN.S214727 ↗
17. BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis10.1186/s12974-020-1704-0 ↗
18. Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering10.1177/2041731419891256 ↗
19. Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat10.1111/jpi.12164 ↗
20. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study10.1186/s12885-018-4151-x ↗
21. Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice10.1186/s13287-020-01680-0 ↗
22. N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model10.1038/s41598-019-44631-3 ↗
23. Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein10.1016/j.apsb.2019.10.002 ↗
24. Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure10.1007/s40820-020-00550-x ↗
25. Urease-Powered Polydopamine Nanomotors for Intravesical Therapy of Bladder Diseases10.1021/acsnano.9b09726 ↗
26. Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery10.1016/j.carbpol.2016.10.021 ↗
27. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins10.1016/j.biomaterials.2011.07.086 ↗
28. Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline10.1016/j.ijbiomac.2020.09.163 ↗
29. Stem cell sheet therapy: another option for acute kidney injury?10.1016/j.kint.2020.08.034 ↗
30. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis10.7150/thno.48080 ↗
31. Efficacy of combination therapy with pentosan polysulfate sodium and adipose tissue-derived stem cells for the management of interstitial cystitis in a rat model10.1016/j.scr.2020.101801 ↗
32. Synergistic Effects of N-Acetylcysteine and Mesenchymal Stem Cell in a Lipopolysaccharide-Induced Interstitial Cystitis Rat Model10.3390/cells9010086 ↗
33. Improvement of Impaired Motor Functions by Human Dental Exfoliated Deciduous Teeth Stem Cell-Derived Factors in a Rat Model of Parkinson's Disease10.3390/ijms21113807 ↗
34. Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome10.1007/s11934-015-0563-1 ↗
35. The use of cell conditioned medium for musculoskeletal tissue regeneration10.1002/jcp.26291 ↗
36. Conditioned medium derived from mesenchymal stem cells culture as a intravesical therapy for cystitis interstitials10.1016/j.mehy.2014.02.027 ↗
37. Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation10.1155/2018/8179013 ↗
38. Partners in Crime: NGF and BDNF in Visceral Dysfunction10.2174/1570159X17666190617095844 ↗
39. Therapeutic effects of inhibition of brain-derived neurotrophic factor on voiding dysfunction in mice with spinal cord injury10.1152/ajprenal.00239.2019 ↗
40. The effect of O-1602, a GPR55 agonist, on the cyclophosphamide-induced rat hemorrhagic cystitis10.1016/j.ejphar.2020.173321 ↗
41. Effects of CYP-Induced Cystitis on Growth Factors and Associated Receptor Expression in Micturition Pathways in Mice with Chronic Overexpression of NGF in Urothelium10.1007/s12031-016-0774-z ↗
42. Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia10.1038/srep32096 ↗
43. TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice10.1172/jci.insight.136007 ↗
44. Sortilin gates neurotensin and BDNF signaling to control peripheral neuropathic pain10.1126/sciadv.aav9946 ↗
45. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis10.1038/nn.3295 ↗
46. Molecular Characterization of GABA-A Receptor Subunit Diversity within Major Peripheral Organs and Their Plasticity in Response to Early Life Psychosocial Stress10.3389/fnmol.2018.00018 ↗
47. Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons10.1016/j.mcn.2012.02.004 ↗
48. Mesenchymal Stem Cell Protection of Neurons against Glutamate Excitotoxicity Involves Reduction of NMDA-Triggered Calcium Responses and Surface GluR1, and Is Partly Mediated by TNF10.3390/ijms19030651 ↗